| Estimating the True Global Burden of Mental Illness E Veno Journal of Clinical & Experimental Oncology 11 (5), 2022 | 2442* | 2022 |
| Endogenous voltage potentials and the microenvironment: bioelectric signals that reveal, induce and normalize cancer B Chernet, M Levin Journal of clinical & experimental oncology, 2013 | 116 | 2013 |
| Probiotics, the New Approach for Cancer Prevention and/or Potentialization of Anti-Cancer Treatment? U Daniluk J Clin Exp Oncol 1 (2), 2012 | 55 | 2012 |
| Biophysics of cancer: cellular excitability (“CELEX”) hypothesis of metastasis MB Djamgoz J Clin Exp Oncol S1 2, 2014 | 45 | 2014 |
| NAD+ in cancer prevention and treatment: pros and cons B Poljsak J. Clin. Exp. Oncol 4, 2, 2016 | 40 | 2016 |
| Expression of voltage-gated sodium channel Nav1. 8 in human prostate cancer is associated with high histological grade S Suy, TP Hansen, HD Auto, BVS Kallakury, V Dailey, M Danner, ... Journal of clinical & experimental oncology 1 (2), 2012 | 34 | 2012 |
| Anticancer laccases: a review TC Guest, S Rashid J. Clin. Exp. Oncol. 5 1, 2, 2016 | 30 | 2016 |
| Gemcitabine-(C4-amide)-[anti-HER2/neu] anti-neoplastic cytotoxicity in dual combination with mebendazole against chemotherapeutic-resistant mammary adenocarcinoma CP Coyne, T Jones, R Bear Journal of clinical & experimental oncology 2 (2), 2013 | 30 | 2013 |
| Roles of NAD (P) H-quinone oxidoreductase 1 (NQO1) on cancer progression and chemoresistance P Srijiwangsa, K Na-Bangchang J. Clin. Exp. Oncol 6 (4), 1-6, 2017 | 23 | 2017 |
| A methylation profile of circulating cell free DNA for the early detection of gastric cancer and the effects after surgical resection D Shin, K Kim, S Choi, H Joo, S Baik J Clin Exp Oncol 5 (1), 2, 2016 | 21 | 2016 |
| Proximal-type epithelioid sarcoma of the head and neck (HN): a study with immunohistochemical and molecular analysis of SMARCB1 R Frank, N Sadri, T Bhatti, JA Biegel, VA LiVolsi, PJ Zhang Journal of clinical & experimental oncology 2 (2), 2013 | 20 | 2013 |
| Quantum magnetic resonance therapy: Targeting biophysical cancer vulnerabilities to effectively treat and palliate R Kumar, M Augustus, AR Nair, R Ebner, GS Nayar J Clin Exp Oncol 5, 2, 2016 | 19 | 2016 |
| The role of MicroRNAs in cancer progression S Norollahi, M Alipour, N Nikbakhsh, H Taheri, MT Hamidian, ... J Clin Exp Oncol 5 (2), 2016 | 18 | 2016 |
| Three dimensional tumor engineering by co-culture of breast tumor and endothelial cells using a hyaluronic acid hydrogel model Y Kassim, E Al Tawil, C Buquet, D Le Cerf, JP Vannier Journal of Clinical & Experimental Oncology 6 (05), 2017 | 16 | 2017 |
| Biomimetic three dimensional cell culturing: colorectal cancer micro-tissue engineering YL Kassim, E Al Tawil, D Le Cerf, J Couteau, T Simon, C Buquet, ... Journal of Clinical & Experimental Oncology 3 (02), 2014 | 14 | 2014 |
| Mechanisms of the formation of peritoneal surface malignancy on omental milky spots from low grade appendiceal mucinous carcinoma Y Yonemura, E Canbay, Y Endou, H Ishibashi, A Mizumoto J Clin Exp Oncol 3 4, 2, 2014 | 13 | 2014 |
| Micro RNA-142-5p Profile as a Predictor of Tumor Markers Regulation in Different Histological Grades of Human Breast Carcinoma MVS Parvathi J Clin Exp Oncol 5 (2), 2016 | 12 | 2016 |
| Early changes in 2D-speckle-tracking echocardiography may predict a decrease in left ventricular ejection fraction in lymphoma patients undergoing anthracycline chemotherapy: a … Y Xu, J Herrmann, PA Pellikka, SM Ansell, SS Cha, HR Villarraga J Clin Exp Oncol 1, 1, 2015 | 12 | 2015 |
| Promoter methylation and loss of expression of PTEN gene in breast cancer patients from Saudi population M Alam, ABA Jerah, AM Ashraf, K Kumaresan, ZM Eisa J Clin Exp Oncol 6, 2, 2017 | 10 | 2017 |
| Mcl-1 is a gate keeper regulating cell death in cancer cells Y Chen, SB Gibson Journal of Clinical & Experimental Oncology 6 (05), 2017 | 10 | 2017 |
Graham ThornicroftInstitute of Psychiatry, Psychology and Neuroscience, King's College London,Verified email at kcl.ac.uk
